会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 0-(Substituted-aminoalkyl)-5-nitroimidazole-(2)-aldoximes
    • O-(取代的 - 氨基烷基)-5-硝基咪唑 - (2) - 肟
    • US3951963A
    • 1976-04-20
    • US448376
    • 1974-03-05
    • Erhardt WinkelmannUlrich GebertWolfgang Raether
    • Erhardt WinkelmannUlrich GebertWolfgang Raether
    • C07D233/95C07D401/12C07D233/32C07D403/12C07D413/12
    • C07D233/95
    • Novel 0-(dialkylaminoalkyl)-1-alkyl-5-nitroimidazole-(2)-aldoximes are described as well as their manufacture and use for treating protozoal diseases. The novel compounds correspond to the general formula ##SPC1##In which R.sup.1 stand for a hydrogen atom, a methyl, ethyl or hydroxyethyl group, Z stands for a linear or branched alkylene chain of 2 to 3 carbon atoms, and R.sup.2 and R.sup.3 each stands for an identical or different lower alkyl radical having from 1 to 4 carbon atoms or the group --NR.sup.2 R.sup.3 can be part of a saturated heterocyclic ring which may contain further substituents preferably a methyl group or/and hetero atoms, such as, especially the pyrrolidine, piperidine, morpholine, thiamorpholine, tetrahydro-1,4-thiazine-1,1-dioxide and piperazine ring, and HX can be a non-toxic, physiologically acceptable acid.
    • 描述了新的O-(二烷基氨基烷基)-1-烷基-5-硝基咪唑 - (2) - 肟类及其制备和用于治疗原生动物疾病的用途。 所述新化合物对应于通式为:其中R 1代表氢原子,甲基,乙基或羟基乙基,Z表示2至3个碳原子的直链或支链亚烷基链,R2和R3各代表相同 或具有1至4个碳原子的不同的低级烷基或基团-NR2R3可以是饱和杂环的一部分,其可以含有其它取代基,优选甲基或/和杂原子,例如特别是吡咯烷,哌啶,吗啉 ,四氢-1,4-噻嗪-1,1-二氧化物和哌嗪环,HX可以是无毒的生理上可接受的酸。